| Literature DB >> 31361944 |
Viivi H A Hirvonen1,2, Katharine Hammond2, Ewa I Chudyk2, Michael A L Limb2, James Spencer3, Adrian J Mulholland2, Marc W van der Kamp1,2.
Abstract
Class A β-lactamases cause clinically relevant resistance to β-lactam antibiotics. Carbapenem degradation is a particular concern. We present an efficient QM/MM molecular simulation protocol that accurately predicts the activity of β-lactamases against carbapenems. Simulations take less than 24 CPU hours, a greater than 99% reduction, and do not require fitting against experimental data or significant parametrization. This computational assay also reveals mechanistic details of β-lactam breakdown and should assist in evaluating emerging β-lactamase variants and developing new antibiotics.Entities:
Year: 2019 PMID: 31361944 DOI: 10.1021/acs.jcim.9b00442
Source DB: PubMed Journal: J Chem Inf Model ISSN: 1549-9596 Impact factor: 4.956